Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2008

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

Abstract

Siemens Healthcare Diagnostics offers comprehensive and flexible solutions for Immunosuppressive Drug Monitoring, designed to meet the needs of our diverse worldwide customer base. Our innovative Dimension® clinical chemistry system (DM) provides a full menu of the only onboard pretreatment whole blood methods available. These methods are easily integrated into the central laboratory - whether you are a large transplantation center, or a small community hospital. The Syva® ISD products have been available since the early 1990's and have been in use in numerous laboratories worldwide. These methods employ the Emit® technology and allow the customer to choose the system that best suits their testing volume needs. The performance is summarized below.

Keywords: cutaneous abscess, osteomylitis, bladder tissue, electrical impedance, first record-able reading, optimal probe pressure

Add Comment 0 Comments

In Press

Original article  

Prediction of Renal Graft Function 1 Year After Adult Deceased-Donor Kidney Transplantation Using Variables...

Ann Transplant In Press; DOI: 10.12659/AOT.944603  

Original article  

Impact of Donor-Recipient Relationship on Long-Term Outcomes in Living-Related Donor Kidney Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.945065  

Case report  

Successful Interventional Therapy for Portal Vein Stenosis after Ex Vivo Liver Resection and Autotransplant...

Ann Transplant In Press; DOI: 10.12659/AOT.944851  

Original article  

Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection

Ann Transplant In Press; DOI: 10.12659/AOT.944762  

Most Viewed Current Articles

05 Apr 2022 : Original article   12,880

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   9,836

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

12 Jan 2022 : Original article   9,289

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

15 Mar 2022 : Case report   7,052

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358